You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR DIPROSONE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DIPROSONE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00910676 ↗ Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors Completed Roche Pharma AG Phase 2 2007-10-01 Patients will receive local prophylactic treatment (Diprosone cream) during 8 weeks from the beginning of the EGF-R inhibitors treatment, on the areas of the body susceptible to be affected by folliculitis.
NCT00910676 ↗ Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors Completed Centre Oscar Lambret Phase 2 2007-10-01 Patients will receive local prophylactic treatment (Diprosone cream) during 8 weeks from the beginning of the EGF-R inhibitors treatment, on the areas of the body susceptible to be affected by folliculitis.
NCT01466478 ↗ An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris Completed LEO Pharma Phase 1 2011-11-01 The purpose of the study is to compare the 3 ointment formulations containing LEO 29102 plus calcipotriol and Daivonex® ointment and Diprosone® ointment and to compare LEO 29102 plus calcipotriol to LEO 29102 alone and to calcipotriol alone in the same ointment vehicle, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.
NCT02376049 ↗ A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) Completed LEO Pharma Phase 1 2015-02-01 An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults with Mild to Moderate Atopic Dermatitis.
NCT02973776 ↗ Vasoconstriction Trial With LEO 90100 Aerosol Foam Completed LEO Pharma Phase 1 2016-12-01 Vasoconstriction study with LEO 90100
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DIPROSONE

Condition Name

Condition Name for DIPROSONE
Intervention Trials
Psoriasis Vulgaris 2
Non-Small-Cell Lung Carcinoma 1
Atopic Dermatitis 1
Metastatic Colorectal Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DIPROSONE
Intervention Trials
Psoriasis 2
Lung Neoplasms 1
Folliculitis 1
Colorectal Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DIPROSONE

Trials by Country

Trials by Country for DIPROSONE
Location Trials
France 3
Canada 1
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DIPROSONE

Clinical Trial Phase

Clinical Trial Phase for DIPROSONE
Clinical Trial Phase Trials
Phase 2 1
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DIPROSONE
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DIPROSONE

Sponsor Name

Sponsor Name for DIPROSONE
Sponsor Trials
LEO Pharma 3
Centre Oscar Lambret 1
Roche Pharma AG 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DIPROSONE
Sponsor Trials
Industry 4
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.